Protagonist Therapeutics, Inc Contract Liability (Deferred Revenue)
Protagonist Therapeutics, Inc (PTGX) had Contract Liability (Deferred Revenue) of $3.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2025-02-21
- 2024-03-31: Contract with Customer, Liability, Current $3.00K.
- 2023-12-31: Contract with Customer, Liability, Current $3.00K.
- 2023-09-30: Contract with Customer, Liability, Current $3.00K.
- 2022-12-31: Contract with Customer, Liability, Current $69.00K.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2024-03-31 | $3.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $3.00K 10-K · filed 2025-02-21 | |
| 2023-09-30 | $3.00K 10-Q · filed 2023-11-02 | |
| 2022-12-31 | $69.00K 10-K · filed 2024-02-27 | |
| 2022-09-30 | $32.00K 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $768.00K 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $899.00K 10-K · filed 2024-02-27 | $1.60M 10-K · filed 2022-02-28 |
| 2021-09-30 | $2.24M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $2.01M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $5.77M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $14.48M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $16.77M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $17.23M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $18.63M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $17.74M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $16.48M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $17.72M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $7.00M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $8.22M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $7.97M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $13.20M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $21.88M 10-Q · filed 2018-08-07 | |
| 2017-12-31 | $31.75M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |